These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21504870)

  • 41. Regulatory decision strategy for entry of a novel biological therapeutic with a clinically unmonitorable toxicity into clinical trials: pre-IND meetings and a case example.
    Black LE; Bendele AM; Bendele RA; Zack PM; Hamilton M
    Toxicol Pathol; 1999; 27(1):22-6. PubMed ID: 10367668
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The challenges involved in modeling toxicity data in silico: a review.
    Gleeson MP; Modi S; Bender A; Robinson RL; Kirchmair J; Promkatkaew M; Hannongbua S; Glen RC
    Curr Pharm Des; 2012; 18(9):1266-91. PubMed ID: 22316153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In silico methods for early toxicity assessment.
    Merlot C
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):80-5. PubMed ID: 18175270
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toward a unifying strategy for the structure-based prediction of toxicological endpoints.
    Carrió P; Sanz F; Pastor M
    Arch Toxicol; 2016 Oct; 90(10):2445-60. PubMed ID: 26553148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational toxicology: Its essential role in reducing drug attrition.
    Naven RT; Louise-May S
    Hum Exp Toxicol; 2015 Dec; 34(12):1304-9. PubMed ID: 26614820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimizing drug discovery by Investigative Toxicology: Current and future trends.
    Beilmann M; Boonen H; Czich A; Dear G; Hewitt P; Mow T; Newham P; Oinonen T; Pognan F; Roth A; Valentin JP; Van Goethem F; Weaver RJ; Birk B; Boyer S; Caloni F; Chen AE; Corvi R; Cronin MTD; Daneshian M; Ewart LC; Fitzgerald RE; Hamilton GA; Hartung T; Kangas JD; Kramer NI; Leist M; Marx U; Polak S; Rovida C; Testai E; Van der Water B; Vulto P; Steger-Hartmann T
    ALTEX; 2019; 36(2):289-313. PubMed ID: 30570669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxicology. Transforming environmental health protection.
    Collins FS; Gray GM; Bucher JR
    Science; 2008 Feb; 319(5865):906-7. PubMed ID: 18276874
    [No Abstract]   [Full Text] [Related]  

  • 49. A research to develop a predicting system of mammalian subacute toxicity. I. Prediction of subacute toxicity using the biological parameters of acute toxicities.
    Yamaguchi T; Nishimura H; Watanabe T; Saito S; Yabuki M; Shiba K; Isobe N; Kishida F; Kumano M; Shono F; Adachi H; Matsuo M
    Chemosphere; 1996 Mar; 32(5):979-98. PubMed ID: 8867144
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FADB: a food additive molecular database for in silico screening in food toxicology.
    Ginex T; Spyrakis F; Cozzini P
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(5):792-8. PubMed ID: 24512305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Making big sense from big data in toxicology by read-across.
    Hartung T
    ALTEX; 2016; 33(2):83-93. PubMed ID: 27032088
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Making in silico predictive models for toxicology FAIR.
    Cronin MTD; Belfield SJ; Briggs KA; Enoch SJ; Firman JW; Frericks M; Garrard C; Maccallum PH; Madden JC; Pastor M; Sanz F; Soininen I; Sousoni D
    Regul Toxicol Pharmacol; 2023 May; 140():105385. PubMed ID: 37037390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health effects of toxicants: Online knowledge support.
    Wexler P; Judson R; de Marcellus S; de Knecht J; Leinala E
    Life Sci; 2016 Jan; 145():284-93. PubMed ID: 26506572
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inroads to predict in vivo toxicology-an introduction to the eTOX Project.
    Briggs K; Cases M; Heard DJ; Pastor M; Pognan F; Sanz F; Schwab CH; Steger-Hartmann T; Sutter A; Watson DK; Wichard JD
    Int J Mol Sci; 2012; 13(3):3820-3846. PubMed ID: 22489185
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prediction of ADMET Properties.
    Norinder U; Bergström CA
    ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FutureTox II: in vitro data and in silico models for predictive toxicology.
    Knudsen TB; Keller DA; Sander M; Carney EW; Doerrer NG; Eaton DL; Fitzpatrick SC; Hastings KL; Mendrick DL; Tice RR; Watkins PB; Whelan M
    Toxicol Sci; 2015 Feb; 143(2):256-67. PubMed ID: 25628403
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Consultancy Activity on In Silico Models for Genotoxic Prediction of Pharmaceutical Impurities.
    Pavan M; Kovarich S; Bassan A; Broccardo L; Yang C; Fioravanzo E
    Methods Mol Biol; 2016; 1425():511-29. PubMed ID: 27311479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ArrayTrack--supporting toxicogenomic research at the U.S. Food and Drug Administration National Center for Toxicological Research.
    Tong W; Cao X; Harris S; Sun H; Fang H; Fuscoe J; Harris A; Hong H; Xie Q; Perkins R; Shi L; Casciano D
    Environ Health Perspect; 2003 Nov; 111(15):1819-26. PubMed ID: 14630514
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The FDA critical path initiative and its influence on new drug development.
    Woodcock J; Woosley R
    Annu Rev Med; 2008; 59():1-12. PubMed ID: 18186700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Research activities in toxicology and toxicological requirements of the FDA for food and color additives.
    Green S
    Biomed Environ Sci; 1988 Dec; 1(4):424-30. PubMed ID: 3077268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.